Recent studies have reported that MIAT participates in chronic lymphocytic leukaemias progression [23] and prostate cancer formation [24]; however, the underlying mechanism of MIAT in tumorigenesis remains unclear. This evidence concerns the gene MIAT and B-cell chronic lymphocytic leukemia.